Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Breakthrough! Phase III Clinical Study of the Chinese New Drug for Alzheimer's Disease Met the Endpoint and is Waiting for Marketing

MuziAugust 02, 2018

Tag: New Drug , Alzheimer's Disease , Shanghai Green Valley Pharmaceutical

PharmaSources Customer Service